Version 5.0, February 2021
This guidance outlines the broad approach adopted by the Therapeutic Goods Administration (TGA) to identify and manage risk associated with therapeutic goods…
Version 5.0, February 2021
This guidance outlines the broad approach adopted by the Therapeutic Goods Administration (TGA) to identify and manage risk associated with therapeutic goods…